Alcohol Use Disorder (AUD)
Also known as: Alcohol abuse, Alcohol dependence, Alcoholism
Methodology & AI Transparency ⓘ
Alcohol Use Disorder (AUD) Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: What is alcohol use disorder (AUD)? For most adults, moderate alcohol use is probably not harmful.
- 2 Real-world patient consensus: Mapped to ADHD, Autism & Behavioral Health under ICD-10-CM F50.0 for Alcohol Use Disorder (AUD) clinical workups.
- 3 Typical cash cost range: Differential triage of Alcohol Use Disorder (AUD) (F50.0) utilizes structured behavioral + in Alcohol Use Disorder (AUD) (F50.0: pharmacologic titration monitoring).
- 4 Top reported side effects / signs: Objective lab/clinical target for Alcohol Use Disorder (AUD): ASRS-v1.1 / Vanderbilt in Alcohol Use Disorder (AUD) (F50.0: Executive Score) (Functional symptom control (F50.0)) and Resting Blood Pressure in Alcohol Use Disorder (AUD) (F50.0: & Pulse (on).
Ask our AI Specialists anything about Alcohol Use Disorder (AUD)
What Is Alcohol Use Disorder (AUD)?
What is alcohol use disorder (AUD)? For most adults, moderate alcohol use is probably not harmful. Your risk of developing an alcohol use disorder (AUD) depends on how much, how often, and how quickly you drink alcohol. Alcohol misuse means that drinking causes distress and harm. Over time alcohol misuse can increase your risk of AUD. AUD can range from mild to severe, depending on the symptoms. Severe AUD is sometimes called alcoholism or alcohol dependence.
Pathophysiology, Underlying Causes & Clinical Presentation
Pathophysiologically, Alcohol Use Disorder (AUD) (ICD-10 F50.0) is driven by norepinephrine alpha-2A) receptor in Alcohol Use Disorder (AUD) (F50.0: under-signaling across executive-control); Cross-referenced with NIH MeSH (Alcoholism), specialists in ADHD, Autism & Behavioral Health monitor Resting Blood Pressure in Alcohol Use Disorder (AUD) (F50.0: & Pulse (on) to gauge tissue recovery.
Common Symptoms & Clinical Signs
- • Craving - a strong need to drink
- • Loss of control - not being able to stop drinking once you've started
- • Presentation of Alcohol Use Disorder (AUD) (F50.0): internal restlessness, impulsive in Alcohol Use Disorder (AUD) (F50.0: interrupting, or emotional)
- • Secondary Alcohol Use Disorder (AUD) clinical sign: compulsive reward-seeking behaviors in Alcohol Use Disorder (AUD) (F50.0: or difficulty moderating)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Alcohol Use Disorder (AUD) Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | F50.0 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | ADHD, Autism & Behavioral Health | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: ASRS-v1.1 / Vanderbilt in Alcohol Use Disorder (AUD) (F50.0: Executive Score) | Functional symptom control (F50.0) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Resting Blood Pressure in Alcohol Use Disorder (AUD) (F50.0: & Pulse (on) | < 125/80 mmHg; HR < 85 bpm (F50.0) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Serum Ferritin & in Alcohol Use Disorder (AUD) (F50.0: Iron Saturation) | Ferritin 50 – 120 ng/mL (F50.0) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Alcohol Use Disorder (AUD)
| Medication | Pharmacologic Class | Patient Worth-It | CMS NADAC / Unit | Typical Lowest Cash |
|---|---|---|---|---|
| Periogard Alcohol Free (Chlorhexidine Gluconate) Periogard Alcohol Free • RxCUI 834137 | Decreased Cell Wall Integrity | 88% | $0.0074 | $ 9.03 /mo |
| Disulfiram Antabuse • RxCUI 197623 | Aldehyde Dehydrogenase Inhibitor | 86% | $1.5721 | $ 61.66 /mo |
| Umcka Coldcare Alcohol-Free (Pelargonium Sidoides) Umcka Coldcare Alcohol-Free • RxCUI RXN-B534995271 | Over-the-Counter Clinical Monograph | 88% | $0.4700 | $ 42.34 /mo |
| Alcohol Plus Brasept Alcocol Gel, Servo-Stat • RxCUI 2048982 | Over-the-Counter Clinical Monograph | 87% | $0.0139 | $ 9.06 /mo |
| Orajel Toothache Rinse (Benzyl Alcohol, Zinc Chloride) Orajel Toothache Rinse • RxCUI 1865199-B10237764 | Pediculicide | 89% | $3.0200 | $ 225.94 /mo |
| Vivitrol (Naltrexone) Vivitrol • RxCUI 1483744-B65757300 | Alcohol Dependence Agent | 86% | $1622.1365 | $ 640.00 /mo |
| Genuine First Aid Alcohol Cleansing Pad (Benzocaine, Alcohol) Genuine First Aid Alcohol Cleansing Pad • RxCUI 1046313-B50814080 | Standardized Chemical Allergen | 76% | $2.9300 | $ 219.46 /mo |
| Physostigmine Salicylate Anticholium • RxCUI 2666367 | FDA Prescription Therapeutic Agent | 94% | $0.2200 | $ 17.41 /mo |
| Plus Brasept Alcocol Gel (Alcohol) Plus Brasept Alcocol Gel • RxCUI 581662 | Over-the-Counter Clinical Monograph | 93% | $0.0139 | $ 9.50 /mo |
| Itch X (Benzyl Alcohol/Pramoxine Hydrochloride) Itch X • RxCUI 1293634 | Pediculicide | 87% | $2.6100 | $ 196.42 /mo |
| Naltrexone Hydrochloride ReVia • RxCUI 1483744 | Opioid Antagonist | 83% | $1.1231 | $ 22.94 /mo |
| Solucion Antiseptica Dermoxine (Solucion Antiseptica Topica A Base De Alcohol Etilico) Solucion Antiseptica Dermoxine • RxCUI RXN-B58345106 | Decreased Cell Wall Integrity | 91% | $3.1300 | $ 233.86 /mo |
| Emory Johns Creek Amenity (Alcohol and Sodium Monofluorophospate) Emory Johns Creek Amenity • RxCUI 545626 | Over-the-Counter Clinical Monograph | 94% | $0.0139 | $ 9.50 /mo |
| Goodsense Artifical Tears (Polyvinyl Alcohol, and Povidone) Goodsense Artifical Tears • RxCUI 598050-B63187893 | Over-the-Counter Clinical Monograph | 78% | $0.3521 | $ 33.85 /mo |
| Orajel 2x Gum Pain Alcohol-Free (Menthol and Hydrogen Peroxide) Orajel 2x Gum Pain Alcohol-Free • RxCUI 2584344 | Over-the-Counter Clinical Monograph | 77% | $0.8804 | $ 71.89 /mo |
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Alcohol Use Disorder (AUD))
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on GLP-1 receptor agonists on the degree of liver fibrosis and CRP in non-alcoholic: What a 2,178-Participant Study Found This study evaluated the efficacy of GLP-1RAs in patients with NAFLD and NASH. Primary care diabetes • 2024-06-15 • Meta-Analysis | N = 2,178 | 99/100 | PMID 38555202 ↗ |
| New Insights on Effects of glucagon-like peptide-1 receptor agonists (GLP1-RAs) on: What a 430-Participant Study Found Observational studies suggest a decrease in alcohol-related events, but RCTs have effects on alcohol consumption and craving that remain non-significant. Addiction science & clinical practice • 2025-12-05 • Meta-Analysis | N = 430 | 97/100 | PMID 41350683 ↗ |
| New Insights on Cenicriviroc Lacked Efficacy to Treat Liver Fibrosis in Nonalcoholic: What a 1,778-Participant Study Found This study did not demonstrate the efficacy of CVC for treating liver fibrosis assessed by histology in adults with NASH; however, CVC was safe and well tolerated in patients with NASH and liver fibrosis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association • 2024-01-15 • Phase III Randomized Trial | N = 1,778 | 96/100 | PMID 37061109 ↗ |
| New Insights on Low-dose ondansetron: A candidate prospective precision medicine to treat alcohol: What a 303-Participant Study Found In this Phase 3 clinical trial, AD04 was shown to be a promising treatment for currently drinking heavy drinking individuals with AUD who also possess a specific genotypic profile in the serotonin transporter and serotonin-3AB... European journal of internal medicine • 2024-09-15 • Phase III Randomized Trial | N = 303 | 93/100 | PMID 38876929 ↗ |
| New Insights on Resmetirom for nonalcoholic fatty liver disease: a randomized, gold-standard: What a 325-Participant Study Found These findings demonstrate resmetirom was safe and well tolerated in adults with presumed NASH, supporting a role for further clinical development. Nature medicine • 2023-11-15 • Phase III Randomized Trial | N = 325 | 93/100 | PMID 37845512 ↗ |
Alcohol Use Disorder (AUD) Patient Community & “People Like Me” Threads
Filter Alcohol Use Disorder (AUD) community threads and patient logs by age, biological sex, dosage, and treatment duration.